Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Kronos Bio  (Stock symbol: KRON )

1300 So. El Camino Real Suite 300
SanMateo, CA 94404
USA
Website Company Summary Management Team
Management

CEO: Norbert W Bischofberger (8/31/2018)
General Management: Jorge DiMartino (12/31/2019)
Finance: Yasir Al-Wakeel (8/19/2020)
Technology: Christopher Dinsmore (6/30/2020)
General Counsel/Legal: Barbara Kosacz
Former Employees: Philip P Gutry
Board

Outside board: (May no longer be on the board) John C Martin (Gilead Sciences) Joshua Kazam (Nile Therapeutics) Arie Belldegrun (Allogene Therapeutics Executive Chairman) Otello Stampacchia (Omega Funds) Rebecka Belldegrun (BellCo Capital CEO/President) Jokob Loven (Nextech Partner) David Tanen (Two River Partner) Roshawn Blunt (1798 Managing Director)
Company

Business description: Kronos Bio is dedicated to the discovery and development of first-in-class therapies that modulate historically undruggable targets. We leverage deep capabilities in high-throughput small molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.
Capital

Rounds: 3
Recent Fundings: Aug 2020   Jul 2019
Capital raised: 278.0M
Last Round: 155.0M
Ownership: Public   Ipo Filing
Stock Symbol: KRON
VCs include: Invus BlackRock ;  T. Rowe Price Associates Fidelity Management and Research Company Omega Funds ;  Nextech Invest ;  Bellco Capital EcoR1 Capital ;  Surveyor Capital Perceptive Advisors Vida Ventures ;  Casdin Partners ;  Commodore Capital ;  Woodline Partners
Corporate investors: GV

Last Tweets


 

Last Mentions


Overview
Record updated: Jul 2022
Sector: Medical Devices & Diagnostics
Year Founded: 2017
Headcount: 101-150 as of Jul 2022
Rounds: 3
Recent Fundings: Aug 2020   Jul 2019
Capital Raised: 278.0M
Last Round: 155.0M
Ownership: Public   Ipo Filing
Stock Symbol: KRON